Termination Decision: Post-DI Settlement | Sep 4, 2024 | PAPER | BOARD |
EXPUNGED | Aug 30, 2024 | PAPER | PATENT OWNER |
EXPUNGED | Aug 30, 2024 | PAPER | PATENT OWNER |
EXPUNGED | Aug 30, 2024 | EXHIBIT | PATENT OWNER |
Joint Motion to Terminate | Aug 30, 2024 | PAPER | PATENT OWNER |
EX2109 | Aug 30, 2024 | EXHIBIT | PATENT OWNER |
Joint Motion to Treat Settlement Agreement as Confidential | Aug 30, 2024 | PAPER | PATENT OWNER |
ORDER Setting Oral Argument | Aug 26, 2024 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Aug 7, 2024 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Aug 7, 2024 | PAPER | PETITIONER |
Patent Owner's Updated Exhibit List | Jul 26, 2024 | PAPER | PATENT OWNER |
Patent Owner's Sur-Reply | Jul 26, 2024 | PAPER | PATENT OWNER |
2108 - 2024.07.16 Jeffrey Ravetch Deposition Transcript (FULL) | Jul 26, 2024 | EXHIBIT | PATENT OWNER |
Notice of Deposition of J. Ravetch, M.D., Ph.D. | Jul 11, 2024 | PAPER | PATENT OWNER |
SECOND MODIFIED SCHEDULING ORDER 37 C.F.R. ยง 42.5(c) | Jul 9, 2024 | PAPER | BOARD |
Exhibit 3005 | Jul 9, 2024 | EXHIBIT | BOARD |
Stipulation Modifying Due Dates | Jul 8, 2024 | PAPER | PATENT OWNER |
Petitioner's Reply ISO Petition | Jun 10, 2024 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Jun 10, 2024 | PAPER | PETITIONER |
Deposition of Arturo Casadevall, January 24, 2020 | Jun 10, 2024 | EXHIBIT | PETITIONER |
Reply Declaration of Jeffrey V. Ravetch, M.D., Ph.D. | Jun 10, 2024 | EXHIBIT | PETITIONER |
Joint Stipulation Modifying Due Dates | May 14, 2024 | PAPER | PETITIONER |
2006 - Dmytrijuk | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2014 - Greenspan | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2023 - CV Arturo Casadevall | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2028 - Hill 2007 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2029 - 1997 FDA pts to Consider MAbs | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2030 - Alexion Press Release 3-16-2007 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2031 - Janeway Appx 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2033 - Kim 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2034 - Hwang 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2035 - Shepherd Appx 2000 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2036 - Lo 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2037 - Welt 1997 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2038 - Haller 2008 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2039 - Torres 2007 PLOS Article | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2040 - Torres 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2042 - Mathieu 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2043 - Andersen 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2044 - Chadd 2001 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2045 - 2007 USP Dictionary of USAN and Int'l Drug Names | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2046 - 1997 INN Naming Guidelines | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2047 - McClean 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2049 - HemeOnc Today | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2050 - Fatimah 2016 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2051 - Foote 1992 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2052- Xiang 1995 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2053 - Soliris Current Label (06-2019 Label) | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2054 - Alexion Press Release 9-20-2006 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2055 - Alexion Press Release 9-26-2006 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2075 - GenScript Final Report | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2086 - Stebbings 2013 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2089 - Generium Elizaria | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2090 - Samsung Biosimilar Pipeline | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2091 - Harlowe and lane 1988 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2104 - 2024.02.23 Jeffrey Ravetch Deposition Transcript (FULL) | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2105 - Declaration of A. Casadevall (for POR) FINAL [149] | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
Patent Owner Response | Mar 12, 2024 | PAPER | PATENT OWNER |
EXPUNGED | Feb 12, 2024 | EXHIBIT | BOARD |
FIRST MODIFIED SCHEDULING ORDER | Feb 12, 2024 | PAPER | BOARD |
Ex 3004 | Feb 12, 2024 | EXHIBIT | BOARD |
Patent Owner's Notice of Deposition of Cindy Ippoliti, Pharm.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Jeffrey V. Ravetch, M.D., Ph.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
Order: Scheduling Order | Dec 20, 2023 | PAPER | BOARD |
Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314 | Dec 8, 2023 | PAPER | BOARD |
US10703809 | Nov 15, 2023 | EXHIBIT | BOARD |
US10590189 | Nov 15, 2023 | EXHIBIT | BOARD |
Patent Owner's Sur-Reply to Petitioner's Reply to Preliminary Response | Oct 20, 2023 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Oct 5, 2023 | PAPER | PETITIONER |
Exhibit 3001 | Sep 22, 2023 | EXHIBIT | BOARD |
Patent Owner Preliminary Response | Sep 12, 2023 | PAPER | PATENT OWNER |
2005 - SOLIRIS Label | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2007 - Janeway and Travers | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2008 - McCloskey | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2009 - Torres | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2010 - Janda | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2011 - Pritsch 1996 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2012 - Pritsch 2000 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2013 - McLean | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2015 - Radbruch | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2016 - Bowdish 7,482,435 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2017 - Hawkins | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2018 - Alexion Pharmaceuticals Form 10K | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2019 - Ricklin and Lambris | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2020 - Alexion Press Release | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2021 - Alexion BusinessWire | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2022 - Arturo Casadevall Declaration 149 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2026 - Michel Nussenzweig Declaration 149 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2098 - Harlow and Lane Chapter 1 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2100 - Rother 2007 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 1 - Prosecution History for US Patent 9,718,880 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 2 - Prosecution History for US Patent 9,718,880 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 1 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 2 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 3 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 4 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 5 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 6 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 7 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 8 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 9 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 10 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 11 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 12 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 13 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 14 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2103 - [1002] Prosecution History for US Patent No. 9,725,504 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
Notice: Notice filing date accorded | Jun 14, 2023 | PAPER | BOARD |
Notice : Power of Attorney | Jun 8, 2023 | PAPER | PATENT OWNER |
Notice : Mandatory Notice | Jun 8, 2023 | PAPER | PATENT OWNER |
Notice : Power of Attorney | May 18, 2023 | PAPER | PETITIONER |
U.S. Patent No. 9,732,149 B2 issued to Leonard Bell et al. | May 18, 2023 | EXHIBIT | PETITIONER |
Prosecution History for U.S. Patent No. 9,732,149 B2 | May 18, 2023 | EXHIBIT | PETITIONER |
Declaration of Jeffrey V. Ravetch, M.D., Ph.D. | May 18, 2023 | EXHIBIT | PETITIONER |
U.S. Patent Application Publication No. 2003/0232972 A1 issued to K Bowdish | May 18, 2023 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,355,245 B1 issued to Mark J. Evans et al. | May 18, 2023 | EXHIBIT | PETITIONER |
Mueller - 34 Molecular Immunology 441 (1997) | May 18, 2023 | EXHIBIT | PETITIONER |
U.S. Pat Appl Publ 2005/0191298 A1 issued to Leonard Bell et al. | May 18, 2023 | EXHIBIT | PETITIONER |
Tacken - 106 Blood 1278 (2005) | May 18, 2023 | EXHIBIT | PETITIONER |
WO 97/11971 issued to Mueller et al. | May 18, 2023 | EXHIBIT | PETITIONER |
Thomas - 33 Molecular Immunology 1389 (1996) | May 18, 2023 | EXHIBIT | PETITIONER |
Hillmen - 350 N. Engl. J. Med 552 (2004) | May 18, 2023 | EXHIBIT | PETITIONER |
Hill - 104 Blood 772a (2004) | May 18, 2023 | EXHIBIT | PETITIONER |
Hill - 106 Blood 2559 (2005) | May 18, 2023 | EXHIBIT | PETITIONER |
Hillmen - 335 N. Engl. J. Med. 1233 (2006) | May 18, 2023 | EXHIBIT | PETITIONER |
Young - 108 Blood 290a (2006) | May 18, 2023 | EXHIBIT | PETITIONER |
Hillmen - 100 Blood 44a (2002) | May 18, 2023 | EXHIBIT | PETITIONER |
Hillmen - 102 Blood 509a (2003) | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpts from 17 WHO Drug Information 115, World Health Organization (2003) | May 18, 2023 | EXHIBIT | PETITIONER |
Guidelines...Use of...(INNs)..., World Health Organization, Geneva (1997) | May 18, 2023 | EXHIBIT | PETITIONER |
Alexion Press Release, Alexion Issued Key C5 Complement Inhibitor...3/15/02 | May 18, 2023 | EXHIBIT | PETITIONER |
WO 2005/007809A2 issued to Rother et al. | May 18, 2023 | EXHIBIT | PETITIONER |
WO 2005/110481A2 issued to Rother | May 18, 2023 | EXHIBIT | PETITIONER |
Kaplan, Eculizumab Alexion, 3 Curr. Opin. Investig. Drugs 1017 (2002) | May 18, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion - IPR2019-00741, #15, Decision dated August 30, 2019 | May 18, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion - IPR2019-00741, #22, PO Response dated Nov. 22, 2019 | May 18, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion - IPR2019-00741, #48, Termination dated June 1, 2020 | May 18, 2023 | EXHIBIT | PETITIONER |
Oppsn File History for European Pat. No. 1 720 571 B1 | May 18, 2023 | EXHIBIT | PETITIONER |
File History for European Patent No. 3 167 888 | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History 11/127,438, Amdmt to Response dated 8/2/2011 | May 18, 2023 | EXHIBIT | PETITIONER |
Appl for Ext. Patent Term ... US Pat 6,355,245 dated May 11, 2007 | May 18, 2023 | EXHIBIT | PETITIONER |
Certificate Ext. Patent Term - US Pat. 6,355,245 dated June 11, 2010 | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpt File History US Pat. 10,590,189 IDS dated May 31, 2019 | May 18, 2023 | EXHIBIT | PETITIONER |
Yoo, 170 J. Immunol. 3134 (2003) | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpt File History US Pat. 10,590,189 NonFinal Rejection 6/11/2019 | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpt File History US Pat 10,590,189 Notice of Allowance 1/22/2020 | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpt File History U.S. Pat 10,590,189 Amdmt in Resp to NonFinal OA 2019 | May 18, 2023 | EXHIBIT | PETITIONER |
Wypych - 283 J. Biol. Chem. 16194 (2008) | May 18, 2023 | EXHIBIT | PETITIONER |
Bournazos - 588 Nature 485 (2020) | May 18, 2023 | EXHIBIT | PETITIONER |
Bournazos - 124 J. Clinical Investigation 725 (2014) | May 18, 2023 | EXHIBIT | PETITIONER |
Baudino - 181 J. Immunology 4107 (2008) | May 18, 2023 | EXHIBIT | PETITIONER |
Takai - 76 Cell 519 (1994) | May 18, 2023 | EXHIBIT | PETITIONER |
Nimmerjahn - 8 Nat. Rev. Immunol. 34 (2008) | May 18, 2023 | EXHIBIT | PETITIONER |
Ravetch - Fc Receptors, 9 Annu. Rev. Immunol. 457 (1991) | May 18, 2023 | EXHIBIT | PETITIONER |
Janeway - Immunobiology...pp. 1-34, 93-122 (5th ed. 2001) | May 18, 2023 | EXHIBIT | PETITIONER |
Excerpts - Juo Conc Dict of Biomedicine and Molecular Biology (2d ed 2001) | May 18, 2023 | EXHIBIT | PETITIONER |
Volkel - 14 Protein Engineering 815 (2001) | May 18, 2023 | EXHIBIT | PETITIONER |
Lobo - 93 Journal of Pharma Sciences 2645 (2004) | May 18, 2023 | EXHIBIT | PETITIONER |
Lipman - 46 ILAR Journal 258 (2005) | May 18, 2023 | EXHIBIT | PETITIONER |
Lo - Methods in Molecular Bio, Vol. 248...pp. 135-159 (2004) | May 18, 2023 | EXHIBIT | PETITIONER |
Riechmann - 332 Nature 323 (1988) | May 18, 2023 | EXHIBIT | PETITIONER |
Reichert - 4 mAbs 413 (2012) | May 18, 2023 | EXHIBIT | PETITIONER |
Alberts - Molecular Biology of the Cell, pp. 551-98 (1994) | May 18, 2023 | EXHIBIT | PETITIONER |
Adderson - 89 J. Clin. Invest. 729 (1992) | May 18, 2023 | EXHIBIT | PETITIONER |
Petition : as filed | May 18, 2023 | PAPER | PETITIONER |